Ziegler Capital Management’s Akcea Therapeutics Inc AKCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-27,567
Closed -$500K 453
2020
Q3
$500K Buy
+27,567
New +$391K 0.02% 372

Ziegler Capital Management's AKCA Position: Q4 2020 in Review

Ziegler Capital Management sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 27,567 shares — an estimated $500K sold.

Ziegler Capital Management first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $500K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Ziegler Capital Management reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Ziegler Capital Management sold 27,567 Akcea Therapeutics Inc shares in Q4 2020, an estimated $500K.
  • Ziegler Capital Management first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
  • Ziegler Capital Management's Akcea Therapeutics Inc position peaked at $500K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Ziegler Capital Management's 13F filing for Q4 2020, filed 5 Feb 2021.